Vita Life Sciences Limited (VLS.AX)
AUD 1.78
(0.0%)
AUD 1.78
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.15 Million AUD | -27.62% |
| 2022 | 15.41 Million AUD | 36.25% |
| 2021 | 11.31 Million AUD | 58.69% |
| 2020 | 7.12 Million AUD | 4.23% |
| 2019 | 6.83 Million AUD | 11.51% |
| 2018 | 6.13 Million AUD | 18.47% |
| 2017 | 5.17 Million AUD | -4.52% |
| 2016 | 5.42 Million AUD | -17.78% |
| 2015 | 6.59 Million AUD | 31.54% |
| 2014 | 5.01 Million AUD | -16.58% |
| 2013 | 6 Million AUD | 7.06% |
| 2012 | 5.61 Million AUD | 51.64% |
| 2011 | 3.7 Million AUD | 7.57% |
| 2010 | 3.44 Million AUD | 37.55% |
| 2009 | 2.5 Million AUD | -1.32% |
| 2008 | 2.53 Million AUD | 28.98% |
| 2007 | 1.96 Million AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 14.77 Million AUD | 0.0% |
| 2023 Q4 | 11.15 Million AUD | 0.0% |
| 2023 FY | 11.15 Million AUD | -27.62% |
| 2023 Q2 | 13.3 Million AUD | 0.0% |
| 2022 Q4 | 15.41 Million AUD | 0.0% |
| 2022 FY | 15.41 Million AUD | 36.25% |
| 2022 Q2 | 14.22 Million AUD | 0.0% |
| 2021 FY | 11.31 Million AUD | 58.69% |
| 2021 Q2 | 7.82 Million AUD | 0.0% |
| 2021 Q4 | 11.31 Million AUD | 0.0% |
| 2020 FY | 7.12 Million AUD | 4.23% |
| 2020 Q2 | 7.39 Million AUD | 0.0% |
| 2020 Q4 | 7.12 Million AUD | 0.0% |
| 2019 Q2 | 7.39 Million AUD | 0.0% |
| 2019 FY | 6.83 Million AUD | 11.51% |
| 2019 Q4 | 6.83 Million AUD | 0.0% |
| 2018 Q2 | 6.21 Million AUD | 0.0% |
| 2018 FY | 6.13 Million AUD | 18.47% |
| 2018 Q4 | 6.13 Million AUD | 0.0% |
| 2017 Q2 | 6.33 Million AUD | 0.0% |
| 2017 Q4 | 5.17 Million AUD | 0.0% |
| 2017 FY | 5.17 Million AUD | -4.52% |
| 2016 Q2 | 7.05 Million AUD | 0.0% |
| 2016 FY | 5.42 Million AUD | -17.78% |
| 2016 Q4 | 5.42 Million AUD | 0.0% |
| 2015 Q2 | 5.02 Million AUD | 0.0% |
| 2015 Q4 | 6.59 Million AUD | 0.0% |
| 2015 FY | 6.59 Million AUD | 31.54% |
| 2014 FY | 5.01 Million AUD | -16.58% |
| 2014 Q4 | 5.01 Million AUD | 0.0% |
| 2014 Q2 | 5.47 Million AUD | 0.0% |
| 2013 Q2 | 6.3 Million AUD | 0.0% |
| 2013 FY | 6 Million AUD | 7.06% |
| 2013 Q4 | 6.11 Million AUD | 0.0% |
| 2012 FY | 5.61 Million AUD | 51.64% |
| 2012 Q4 | 5.61 Million AUD | 0.0% |
| 2011 FY | 3.7 Million AUD | 7.57% |
| 2011 Q4 | 3.7 Million AUD | 0.0% |
| 2010 Q4 | 3.44 Million AUD | 0.0% |
| 2010 FY | 3.44 Million AUD | 37.55% |
| 2009 Q4 | 2.5 Million AUD | 0.0% |
| 2009 FY | 2.5 Million AUD | -1.32% |
| 2008 FY | 2.53 Million AUD | 28.98% |
| 2008 Q4 | 2.53 Million AUD | 0.0% |
| 2007 FY | 1.96 Million AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Althea Group Holdings Limited | 3.98 Million AUD | -180.015% |
| Cann Group Limited | 10.18 Million AUD | -9.461% |
| ECS Botanics Holdings Ltd | 12.98 Million AUD | 14.095% |
| Ecofibre Limited | 2.63 Million AUD | -324.068% |
| Elixinol Wellness Limited | 3.66 Million AUD | -204.394% |
| Hygrovest Limited | - AUD | -Infinity% |
| IDT Australia Limited | 1.68 Million AUD | -563.474% |
| Invion Limited | -1.21 Million AUD | 1021.431% |
| Little Green Pharma Ltd | 8.9 Million AUD | -25.186% |
| Live Verdure Ltd | 439.91 Thousand AUD | -2435.28% |
| Medical Developments International Limited | 8.77 Million AUD | -27.158% |
| Vitura Health Limited | 5.01 Million AUD | -122.585% |